<?xml version="1.0" encoding="UTF-8"?>
<document id="29844165">
	<sentence id="s1" text="PEPCK-M (PCK2), the mitochondrial isoform of phosphoenolpyruvate carboxykinase (PEPCK), has been shown by us and others to be functionally expressed and to mediate gluconeogenesis, the reverse pathway of glycolysis, in different cancer cells.">
		<entity id="s1.e1" charOffset="0-5"
			type="GENE" text="PEPCK" ontology_id="5106"/>
		<entity id="s1.e2" charOffset="9-13"
			type="GENE" text="PCK2" ontology_id="5106"/>
		<entity id="s1.e3" charOffset="229-235"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s1.p1" e1="s1.e3"
		    e2="s1.e3" pgr="false"/>
		<pair id="s1.p2" e1="s1.e1"
		    e2="s1.e3" pgr="false"/>
	</sentence>
	<sentence id="s2" text="Serine and ribose synthesis have been identified as downstream pathways fed by PEPCK in cancer cells.">
		<entity id="s2.e1" charOffset="79-84"
			type="GENE" text="PEPCK" ontology_id="5106"/>
		<entity id="s2.e2" charOffset="88-94"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
	</sentence>
	<sentence id="s3" text="This pathway is required to maintain levels of GPL, especially phosphatidylethanolamine (PE), as shown by stable shRNA-mediated silencing of PEPCK-M in H23 lung cancer cells.">
		<entity id="s3.e1" charOffset="141-146"
			type="GENE" text="PEPCK" ontology_id="5106"/>
		<entity id="s3.e2" charOffset="161-167"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e2" pgr="false"/>
	</sentence>
	<sentence id="s4" text="Furthermore, PEPCK-M silencing abrogated cancer growth in a lung cancer cell xenograft model.">
		<entity id="s4.e1" charOffset="13-18"
			type="GENE" text="PEPCK" ontology_id="5106"/>
		<entity id="s4.e2" charOffset="41-47"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s4.p1" e1="s4.e1"
		    e2="s4.e2" pgr="false"/>
	</sentence>
	<sentence id="s5" text="In conclusion, glycerol phosphate formation for de novo GPL synthesis via glyceroneogenesis is a newly characterized anabolic pathway in cancer cells mediated by PEPCK-M under conditions of severe nutrient deprivation">
		<entity id="s5.e1" charOffset="137-143"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s5.e2" charOffset="162-167"
			type="GENE" text="PEPCK" ontology_id="5106"/>
		<pair id="s5.p1" e1="s5.e1"
		    e2="s5.e2" pgr="false"/>
	</sentence>
	<sentence id="s6" text="Here, we report that PEPCK-M-dependent glycerol phosphate formation from noncarbohydrate precursors (glyceroneogenesis) occurs in starved lung cancer cells and supports de novo glycerophospholipid synthesis.">
		<entity id="s6.e1" charOffset="21-26"
			type="GENE" text="PEPCK" ontology_id="5106"/>
		<entity id="s6.e2" charOffset="143-149"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s6.p1" e1="s6.e1"
		    e2="s6.e2" pgr="false"/>
	</sentence>
</document>
